- Home
- LNG vs CAH Comparison
LNG vs CAH Comparison
Compare LNG & CAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LNG | CAH |
|---|---|---|
| Founded | 1983 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil/Gas Transmission | Other Pharmaceuticals |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.5B | 52.0B |
| IPO Year | 1996 | 1994 |
Fundamental Metrics
Financial Performance| Metric | LNG | CAH |
|---|---|---|
| Price | $226.47 | $224.44 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 11 |
| Target Price | ★ $265.50 | $229.09 |
| AVG Volume (30 Days) | 1.5M | ★ 1.6M |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | ★ 0.98% | 0.92% |
| EPS Growth | N/A | ★ 86.96 |
| EPS | ★ 13.59 | 1.88 |
| Revenue | $15,703,000,000.00 | ★ $222,578,000,000.00 |
| Revenue This Year | $30.28 | $17.34 |
| Revenue Next Year | $12.13 | $8.95 |
| P/E Ratio | ★ $16.66 | $119.38 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $186.20 | $120.72 |
| 52 Week High | $246.42 | $230.20 |
Technical Indicators
Market Signals| Indicator | LNG | CAH |
|---|---|---|
| Relative Strength Index (RSI) | 70.45 | 56.04 |
| Support Level | $206.19 | $213.75 |
| Resistance Level | $228.04 | $225.91 |
| Average True Range (ATR) | 4.23 | 6.65 |
| MACD | 0.89 | -0.04 |
| Stochastic Oscillator | 89.52 | 68.97 |
Price Performance
Historical ComparisonAbout LNG Cheniere Energy Inc.
Cheniere Energy is a liquified natural gas, or LNG, producer with two facilities in Corpus Christi, Texas and Sabine Pass, Louisiana. It generates most of its revenue through long-term contracts with customers on a fixed and variable fee payout structure. It also generates revenue by selling uncontracted LNG to customers on a short or one-time basis. A subsidiary, Cheniere Energy Partners, owns the Sabine Pass facility and trades as a master limited partnership.
About CAH Cardinal Health Inc.
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.